Full Text View
Tabular View
No Study Results Posted
Related Studies
A First Human Dose Study to Investigate Safety and Tolerability of LY2979165 in Healthy Volunteers
This study has been completed.
Study NCT01248052   Information provided by Eli Lilly and Company

First Received on November 23, 2010.   Last Updated on June 24, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Bipolar Disorder
More general conditions related to this trial
Affective Disorders, Psychotic
Mental Disorders
Mood Disorders
Interventions listed in this trial
LY2979165
Placebo
Sponsors listed in this trial
Eli Lilly and Company


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services